View Amendment Current Amendment: 2 to Bill 1035 Rep. HORNE proposes the following Amendment No. 2 to S. 1035 (COUNCIL\MS\1035C001.MS.VR14):

Reference is to Printer's Date 5/7/14-H.

Amend the bill, as and if amended, by adding an appropriately numbered SECTION to read:

/      SECTION      __.      (A)      There is created a study committee whose purpose is to develop a plan for the sale and use of medical marijuana in the State should the Drug Enforcement Administration declassify or reclassify marijuana as a controlled substance.
     (B)(1)      Members of the study committee must include:
           (a)      the Director or a designee of the Department of Agriculture;
           (b)      the Director or a designee of the Department of Health and Environmental Control;
           (c)      the Director or a designee of the Department of Revenue;
           (d)      the Director of a designee of the State Law Enforcement Division;
           (e)      two members of the House of Representatives appointed by the Speaker of the House, one of whom the Speaker shall designate as a co-chair of the study committee;
           (f)      two members of the Senate appointed by the President Pro Tempore of the Senate, one of whom the President Pro Tempore shall designate as a co-chair of the study committee;
           (g)      one member of the public appointed by the Speaker of the House of Representatives;
           (h)      one member of the public appointed by the President Pro Tempore of the Senate;
           (i)      the President or a designee of the Medical University of South Carolina; and
           (j)      the President or a designee of Clemson University.
           (2)      The study committee also may invite representatives of non-profit entities with expertise in the production of CBD oil to participate in the study committee process.
           (3)      The House of Representatives Judiciary Committee and the Senate Medical Affairs Committee shall designate staff to assist the study committee.
     (C)      The study committee shall provide a report with findings and recommendations to the House of Representatives and the Senate by March 15, 2015, at which the study committee shall dissolve. The report must address, at a minimum, methods and procedures for cultivating medical marijuana in the State, the amount of tax to impose on the sale of medical marijuana, the need for an agriculture marketing plan for the sale and use of medical marijuana, and the impact of the sale and use of medical marijuana on public health and wellness. /

Renumber sections to conform.
Amend title to conform.